Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


Articles published in Neurochem Res

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    November 2022
  1. AL-KURAISHY HM, Al-Gareeb AI, Alsayegh AA, Hakami ZH, et al
    A Potential Link Between Visceral Obesity and Risk of Alzheimer's Disease.
    Neurochem Res. 2022 Nov 21. doi: 10.1007/s11064-022-03817.
    PubMed     Abstract available


  2. LIU M, Lian B, Lan Z, Sun H, et al
    Transcriptomic Profile Identifies Hippocampal Sgk1 as the Key Mediator of Ovarian Estrogenic Regulation on Spatial Learning and Memory and Abeta Accumulation.
    Neurochem Res. 2022;47:3369-3384.
    PubMed     Abstract available


    October 2022
  3. WU Y, Hang Z, Lei T, Du H, et al
    Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones.
    Neurochem Res. 2022 Oct 30. pii: 10.1007/s11064-022-03784.
    PubMed     Abstract available


  4. KIRSTEIN M, Cambrils A, Segarra A, Melero A, et al
    Cholinergic Senescence in the Ts65Dn Mouse Model for Down Syndrome.
    Neurochem Res. 2022;47:3076-3092.
    PubMed     Abstract available


    September 2022
  5. SEYEDAGHAMIRI F, Rajabi M, Mohaddes G
    Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments.
    Neurochem Res. 2022 Sep 1. pii: 10.1007/s11064-022-03734.
    PubMed     Abstract available


  6. HAMAGUCHI T, Ono K, Yamada M
    Transmission of Cerebral beta-Amyloidosis Among Individuals.
    Neurochem Res. 2022;47:2469-2477.
    PubMed     Abstract available


  7. NOPPARAT C, Chaopae W, Boontem P, Sopha P, et al
    Melatonin Attenuates High Glucose-Induced Changes in Beta Amyloid Precursor Protein Processing in Human Neuroblastoma Cells.
    Neurochem Res. 2022;47:2568-2579.
    PubMed     Abstract available


    August 2022
  8. BHATIA S, Singh M, Singh T, Singh V, et al
    Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer's Disease.
    Neurochem Res. 2022 Aug 20. pii: 10.1007/s11064-022-03722.
    PubMed     Abstract available


  9. DE ALMEIDA EJR, Ibrahim HJ, Chitolina Schetinger MR, de Andrade CM, et al
    Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.
    Neurochem Res. 2022 Aug 13. pii: 10.1007/s11064-022-03713.
    PubMed     Abstract available


  10. LUO JS, Ning JQ, Chen ZY, Li WJ, et al
    The Role of Mitochondrial Quality Control in Cognitive Dysfunction in Diabetes.
    Neurochem Res. 2022;47:2158-2172.
    PubMed     Abstract available


  11. WANG X, Li B, Yu X, Zhou Y, et al
    The Neuroprotective Effect of GM-1 Ganglioside on the Amyloid-Beta-Induced Oxidative Stress in PC-12 Cells Mediated by Nrf-2/ARE Signaling Pathway.
    Neurochem Res. 2022;47:2405-2415.
    PubMed     Abstract available


  12. IBI D, Kondo S, Ohmi A, Kojima Y, et al
    Preventive Effect of Betaine Against Cognitive Impairments in Amyloid beta Peptide-Injected Mice Through Sirtuin1 in Hippocampus.
    Neurochem Res. 2022;47:2333-2344.
    PubMed     Abstract available


    July 2022
  13. KHEZRI MR, Ghasemnejad-Berenji M
    Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
    Neurochem Res. 2022 Jul 8. pii: 10.1007/s11064-022-03667.
    PubMed     Abstract available


    June 2022
  14. CHINO K, Izuo N, Noike H, Uno K, et al
    Shati/Nat8l Overexpression Improves Cognitive Decline by Upregulating Neuronal Trophic Factor in Alzheimer's Disease Model Mice.
    Neurochem Res. 2022 Jun 27. pii: 10.1007/s11064-022-03649.
    PubMed     Abstract available


    May 2022
  15. EL-GANAINY SO, Soliman OA, Ghazy AA, Allam M, et al
    Intranasal Oxytocin Attenuates Cognitive Impairment, beta-Amyloid Burden and Tau Deposition in Female Rats with Alzheimer's Disease: Interplay of ERK1/2/GSK3beta/Caspase-3.
    Neurochem Res. 2022 May 20. pii: 10.1007/s11064-022-03624.
    PubMed     Abstract available


  16. THENMOZHI AJ, Raja TRW, Janakiraman U, Manivasagam T, et al
    Correction to: Neuroprotective Effect of Hesperidin on Aluminium Chloride Induced Alzheimer's Disease in Wistar Rats.
    Neurochem Res. 2022 May 4. pii: 10.1007/s11064-022-03616.
    PubMed    


  17. MANDAL PK, Guha Roy R, Samkaria A, Maroon JC, et al
    In Vivo (13)C Magnetic Resonance Spectroscopy for Assessing Brain Biochemistry in Health and Disease.
    Neurochem Res. 2022;47:1183-1201.
    PubMed     Abstract available


  18. ERDOGAN MA, Kirazlar M, Yigitturk G, Erbas O, et al
    Digoxin Exhibits Neuroprotective Properties in a Rat Model of Dementia.
    Neurochem Res. 2022;47:1290-1298.
    PubMed     Abstract available


    April 2022
  19. GHOLIPOUR P, Komaki A, Parsa H, Ramezani M, et al
    Therapeutic Effects of High-Intensity Interval Training Exercise Alone and Its Combination with Ecdysterone Against Amyloid Beta-Induced Rat Model of Alzheimer's Disease: A Behavioral, Biochemical, and Histological Study.
    Neurochem Res. 2022 Apr 29. pii: 10.1007/s11064-022-03603.
    PubMed     Abstract available


    March 2022
  20. SUNKARIA A, Bhardwaj S
    Sleep Disturbance and Alzheimer's Disease: The Glial Connection.
    Neurochem Res. 2022 Mar 18. pii: 10.1007/s11064-022-03578.
    PubMed     Abstract available


  21. NGUYEN TT, Hulme J, Vo TK, Van Vo G, et al
    The Potential Crosstalk Between the Brain and Visceral Adipose Tissue in Alzheimer's Development.
    Neurochem Res. 2022 Mar 17. pii: 10.1007/s11064-022-03569.
    PubMed     Abstract available


  22. MENG S, Wang B, Li W
    CircAXL Knockdown Alleviates Abeta1-42-Induced Neurotoxicity in Alzheimer's Disease via Repressing PDE4A by Releasing miR-1306-5p.
    Neurochem Res. 2022 Mar 1. pii: 10.1007/s11064-022-03563.
    PubMed     Abstract available


    February 2022
  23. FRONZA MG, Sacramento M, Alves D, Pratico D, et al
    1-(7-Chloroquinolin-4-yl)-N-(4-Methoxybenzyl)-5-Methyl-1H-1,2, 3-Triazole-4- carboxamide Reduces Abeta Formation and Tau Phosphorylation in Cellular Models of Alzheimer's Disease.
    Neurochem Res. 2022 Feb 15. pii: 10.1007/s11064-021-03514.
    PubMed     Abstract available


  24. SHARMA VK, Singh TG, Prabhakar NK, Mannan A, et al
    Kynurenine Metabolism and Alzheimer's Disease: The Potential Targets and Approaches.
    Neurochem Res. 2022 Feb 8. pii: 10.1007/s11064-022-03546.
    PubMed     Abstract available


  25. SHUKLA M, Wongchitrat P, Govitrapong P
    A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies-Emphasis on Alzheimer's Disease Pathogenesis.
    Neurochem Res. 2022 Feb 5. pii: 10.1007/s11064-022-03530.
    PubMed     Abstract available


    January 2022
  26. POLIS B, Squillario M, Gurevich V, Srikanth KD, et al
    Effects of Chronic Arginase Inhibition with Norvaline on Tau Pathology and Brain Glucose Metabolism in Alzheimer's Disease Mice.
    Neurochem Res. 2022 Jan 31. pii: 10.1007/s11064-021-03519.
    PubMed     Abstract available


  27. YU H, Shi J, Lin Y, Zhang Y, et al
    Icariin Ameliorates Alzheimer's Disease Pathology by Alleviating Myelin Injury in 3 x Tg-AD Mice.
    Neurochem Res. 2022 Jan 17. pii: 10.1007/s11064-021-03507.
    PubMed     Abstract available


    December 2021
  28. LIU M, Zhang X, Wang Y
    Curcumin Alleviates Abeta42-Induced Neuronal Metabolic Dysfunction via the Thrb/SIRT3 Axis and Improves Cognition in APPTG Mice.
    Neurochem Res. 2021;46:3166-3178.
    PubMed     Abstract available


    October 2021
  29. ROE K
    An Alternative Explanation for Alzheimer's Disease and Parkinson's Disease Initiation from Specific Antibiotics, Gut Microbiota Dysbiosis and Neurotoxins.
    Neurochem Res. 2021 Oct 20. pii: 10.1007/s11064-021-03467.
    PubMed     Abstract available


  30. VERKERKE M, Hol EM, Middeldorp J
    Physiological and Pathological Ageing of Astrocytes in the Human Brain.
    Neurochem Res. 2021;46:2662-2675.
    PubMed     Abstract available


    September 2021
  31. WAN T, Fu M, Jiang Y, Jiang W, et al
    Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer's Disease.
    Neurochem Res. 2021 Sep 13. pii: 10.1007/s11064-021-03448.
    PubMed     Abstract available


  32. JIANG P, Chen L, Xu J, Liu W, et al
    Neuroprotective Effects of Rhynchophylline Against Abeta1-42-Induced Oxidative Stress, Neurodegeneration, and Memory Impairment Via Nrf2-ARE Activation.
    Neurochem Res. 2021;46:2439-2450.
    PubMed     Abstract available


    August 2021
  33. SHARMA VK, Singh TG, Singh S, Garg N, et al
    Apoptotic Pathways and Alzheimer's Disease: Probing Therapeutic Potential.
    Neurochem Res. 2021 Aug 12. pii: 10.1007/s11064-021-03418.
    PubMed     Abstract available


  34. KAUR D, Behl T, Sehgal A, Singh S, et al
    Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.
    Neurochem Res. 2021 Aug 6. pii: 10.1007/s11064-021-03415.
    PubMed     Abstract available


    May 2021
  35. ELFOULY A, Awny M, Ibrahim MK, Aboelsaad M, et al
    Effects of Long-Acting Testosterone Undecanoate on Behavioral Parameters and Na + , K(+)-ATPase mRNA Expression in Mice with Alzheimer`s Disease.
    Neurochem Res. 2021 May 25. pii: 10.1007/s11064-021-03357.
    PubMed     Abstract available


  36. XIAN-HUI D, Dong-Xue M, Tian-Ci Z, Xiao-Ping H, et al
    The Effect of TCM-Induced HAMP on Key Enzymes in the Hydrolysis of AD Model Cells.
    Neurochem Res. 2021;46:1068-1080.
    PubMed     Abstract available


    April 2021
  37. LEHMANN L, Lo A, Knox KM, Barker-Haliski M, et al
    Alzheimer's Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation.
    Neurochem Res. 2021 Apr 30. pii: 10.1007/s11064-021-03332.
    PubMed     Abstract available


  38. NAZIR S, Anwar F, Saleem U, Ahmad B, et al
    Drotaverine Inhibitor of PDE4: Reverses the Streptozotocin Induced Alzheimer's Disease in Mice.
    Neurochem Res. 2021 Apr 20. pii: 10.1007/s11064-021-03327.
    PubMed     Abstract available


  39. UDDIN MS, Sumsuzzman DM, Jeandet P, Behl T, et al
    Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease.
    Neurochem Res. 2021 Apr 19. pii: 10.1007/s11064-021-03325.
    PubMed     Abstract available


  40. CAO B, Zeng M, Zhang Q, Zhang B, et al
    Amentoflavone Ameliorates Memory Deficits and Abnormal Autophagy in Abeta25-35-Induced Mice by mTOR Signaling.
    Neurochem Res. 2021;46:921-934.
    PubMed     Abstract available


  41. HACIOGLU C, Kar F, Kanbak G
    Ex Vivo Investigation of Bexarotene and Nicotinamide Function as a Protective Agent on Rat Synaptosomes Treated with Abeta(1-42).
    Neurochem Res. 2021;46:804-818.
    PubMed     Abstract available


    March 2021
  42. SALCEDO C, Wagner A, Andersen JV, Vinten KT, et al
    Downregulation of GABA Transporter 3 (GAT3) is Associated with Deficient Oxidative GABA Metabolism in Human Induced Pluripotent Stem Cell-Derived Astrocytes in Alzheimer's Disease.
    Neurochem Res. 2021 Mar 12. pii: 10.1007/s11064-021-03276.
    PubMed     Abstract available


  43. BABAEI P, Eyvani K, Kouhestani S
    Sex-Independent Cognition Improvement in Response to Kaempferol in the Model of Sporadic Alzheimer's Disease.
    Neurochem Res. 2021 Mar 12. pii: 10.1007/s11064-021-03289.
    PubMed     Abstract available


    February 2021
  44. LI J, Xu C, Zhang J, Jin C, et al
    Identification of miRNA-Target Gene Pairs in the Parietal and Frontal Lobes of the Brain in Patients with Alzheimer's Disease Using Bioinformatic Analyses.
    Neurochem Res. 2021 Feb 13. pii: 10.1007/s11064-020-03215.
    PubMed     Abstract available


  45. XU Y, Cheng L, Sun J, Li F, et al
    Hypermethylation of Mitochondrial Cytochrome b and Cytochrome c Oxidase II Genes with Decreased Mitochondrial DNA Copy Numbers in the APP/PS1 Transgenic Mouse Model of Alzheimer's Disease.
    Neurochem Res. 2021 Feb 12. pii: 10.1007/s11064-020-03192.
    PubMed     Abstract available


  46. LIU X, Wang K, Wei X, Xie T, et al
    Interaction of NF-kappaB and Wnt/beta-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments.
    Neurochem Res. 2021 Feb 1. pii: 10.1007/s11064-021-03227.
    PubMed     Abstract available


  47. GAO Y, Zhang J, Li S, Zhang Y, et al
    Cattle Encephalon Glycoside and Ignotin Protects Neurons Against Microglia-Induced Neuroinflammation via Elevating BDNF Expression and Inhibiting TLR4/NF-kappaB Pathway.
    Neurochem Res. 2021;46:326-336.
    PubMed     Abstract available


  48. CHU F, Li K, Li X, Xu L, et al
    Graphene Oxide Ameliorates the Cognitive Impairment Through Inhibiting PI3K/Akt/mTOR Pathway to Induce Autophagy in AD Mouse Model.
    Neurochem Res. 2021;46:309-325.
    PubMed     Abstract available


    January 2021
  49. ALI M, Saleem U, Anwar F, Imran M, et al
    Screening of Synthetic Isoxazolone Derivative Role in Alzheimer's Disease: Computational and Pharmacological Approach.
    Neurochem Res. 2021 Jan 24. pii: 10.1007/s11064-021-03229.
    PubMed     Abstract available


  50. LARANJINHA J, Nunes C, Ledo A, Lourenco C, et al
    The Peculiar Facets of Nitric Oxide as a Cellular Messenger: From Disease-Associated Signaling to the Regulation of Brain Bioenergetics and Neurovascular Coupling.
    Neurochem Res. 2021;46:64-76.
    PubMed     Abstract available


  51. GONZALEZ A
    Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.
    Neurochem Res. 2021;46:34-50.
    PubMed     Abstract available


    November 2020
  52. BALCAR VJ, Zeman T, Janout V, Janoutova J, et al
    Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer's Disease in a Central European Population.
    Neurochem Res. 2020 Nov 18. pii: 10.1007/s11064-020-03176.
    PubMed     Abstract available


  53. BAGHERI-MOHAMMADI S
    Microglia in Alzheimer's Disease: The Role of Stem Cell-Microglia Interaction in Brain Homeostasis.
    Neurochem Res. 2020 Nov 10. pii: 10.1007/s11064-020-03162.
    PubMed     Abstract available


  54. DING Y, Liu H, Cen M, Tao Y, et al
    Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice.
    Neurochem Res. 2020 Nov 2. pii: 10.1007/s11064-020-03160.
    PubMed     Abstract available


    October 2020
  55. ORTIZ CJC, Damasio CM, Pruccoli L, Nadur NF, et al
    Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases.
    Neurochem Res. 2020 Oct 20. pii: 10.1007/s11064-020-03148.
    PubMed     Abstract available


    April 2020
  56. GE Y, Song X, Liu J, Liu C, et al
    The Combined Therapy of Berberine Treatment with lncRNA BACE1-AS Depletion Attenuates Abeta25-35 Induced Neuronal Injury Through Regulating the Expression of miR-132-3p in Neuronal Cells.
    Neurochem Res. 2020;45:741-751.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: